Steven Reichling, Chief Financial Officer at Accelerate Diagnostics, Inc (AXDX), bought 5,000 shares at $1.39 ($7K) on 2022-08-22, disclosed to the SEC on 2022-08-22.
Open-market purchase of $7k AXDX by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| AXDX | SELL | 2023-02-15 | $3K | — | Filing → |
| AXDX | SELL | 2023-01-17 | $3K | — | Filing → |
| AXDX | SELL | 2022-04-28 | $29K | — | Filing → |